These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 7553641

  • 21. Androgen deprivation induces selective outgrowth of aggressive hormone-refractory prostate cancer clones expressing distinct cellular and molecular properties not present in parental androgen-dependent cancer cells.
    Tso CL, McBride WH, Sun J, Patel B, Tsui KH, Paik SH, Gitlitz B, Caliliw R, van Ophoven A, Wu L, deKernion J, Belldegrun A.
    Cancer J; 2000; 6(4):220-33. PubMed ID: 11038142
    [Abstract] [Full Text] [Related]

  • 22. Human melanoma cell lines selected in vitro displaying various levels of drug resistance against cisplatin, fotemustine, vindesine or etoposide: modulation of proto-oncogene expression.
    Kern MA, Helmbach H, Artuc M, Karmann D, Jurgovsky K, Schadendorf D.
    Anticancer Res; 1997; 17(6D):4359-70. PubMed ID: 9494534
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Antisense TRPM-2 oligodeoxynucleotides chemosensitize human androgen-independent PC-3 prostate cancer cells both in vitro and in vivo.
    Miyake H, Chi KN, Gleave ME.
    Clin Cancer Res; 2000 May; 6(5):1655-63. PubMed ID: 10815883
    [Abstract] [Full Text] [Related]

  • 25. Transcription of genes encoding granulocyte-macrophage colony-stimulating factor, interleukin 3, and interleukin 6 receptors and lack of proliferative response to exogenous cytokines in nonhematopoietic human malignant cell lines.
    Guillaume T, Sekhavat M, Rubinstein DB, Hamdan O, Symann ML.
    Cancer Res; 1993 Jul 01; 53(13):3139-44. PubMed ID: 8319222
    [Abstract] [Full Text] [Related]

  • 26. Enhancement of Fas-mediated apoptosis in renal cell carcinoma cells by adriamycin.
    Wu XX, Mizutani Y, Kakehi Y, Yoshida O, Ogawa O.
    Cancer Res; 2000 Jun 01; 60(11):2912-8. PubMed ID: 10850437
    [Abstract] [Full Text] [Related]

  • 27. Adrenomedullin prevents apoptosis in prostate cancer cells.
    Abasolo I, Montuenga LM, Calvo A.
    Regul Pept; 2006 Jan 15; 133(1-3):115-22. PubMed ID: 16297990
    [Abstract] [Full Text] [Related]

  • 28. Enhanced activity of estramustine, vinblastine, etoposide, and suramin in prostate carcinoma.
    Arah IN, Dixon SC, Horti J, Figg WD.
    Neoplasma; 1999 Jan 15; 46(2):117-23. PubMed ID: 10466436
    [Abstract] [Full Text] [Related]

  • 29. Effects of all-trans retinoic acid and antireceptor antibodies on growth and programmed cell death of human myeloma cells.
    Taetle R, Dos Santos B, Akamatsu K, Koishihara Y, Ohsugi Y.
    Clin Cancer Res; 1996 Feb 15; 2(2):253-9. PubMed ID: 9816167
    [Abstract] [Full Text] [Related]

  • 30. Retinoic acid induces expression of the interleukin-1beta gene in cultured normal human mammary epithelial cells and in human breast carcinoma lines.
    Liu L, Gudas LJ.
    J Cell Physiol; 2002 Nov 15; 193(2):244-52. PubMed ID: 12385002
    [Abstract] [Full Text] [Related]

  • 31. Distinctive potentiating effects of cisplatin and/or ifosfamide combined with etoposide in human small cell lung carcinoma xenografts.
    Nemati F, Livartowski A, De Cremoux P, Bourgeois Y, Arvelo F, Pouillart P, Poupon MF.
    Clin Cancer Res; 2000 May 15; 6(5):2075-86. PubMed ID: 10815935
    [Abstract] [Full Text] [Related]

  • 32. Overcoming tumor necrosis factor and drug resistance of human tumor cell lines by combination treatment with anti-Fas antibody and drugs or toxins.
    Morimoto H, Yonehara S, Bonavida B.
    Cancer Res; 1993 Jun 01; 53(11):2591-6. PubMed ID: 7684321
    [Abstract] [Full Text] [Related]

  • 33. Anti-gout agent allopurinol exerts cytotoxicity to human hormone-refractory prostate cancer cells in combination with tumor necrosis factor-related apoptosis-inducing ligand.
    Yasuda T, Yoshida T, Goda AE, Horinaka M, Yano K, Shiraishi T, Wakada M, Mizutani Y, Miki T, Sakai T.
    Mol Cancer Res; 2008 Dec 01; 6(12):1852-60. PubMed ID: 19074830
    [Abstract] [Full Text] [Related]

  • 34. A novel hydroxamic acid compound, BMD188, demonstrates anti-prostate cancer effects by inducing apoptosis. I: In vitro studies.
    Li L, Zhu Z, Joshi B, Porter AT, Tang DG.
    Anticancer Res; 1999 Dec 01; 19(1A):51-60. PubMed ID: 10226524
    [Abstract] [Full Text] [Related]

  • 35. Effects of c-myc oncogene modulation on drug resistance in human small cell lung carcinoma cell lines.
    Van Waardenburg RC, Prins J, Meijer C, Uges DR, De Vries EG, Mulder NH.
    Anticancer Res; 1996 Dec 01; 16(4A):1963-70. PubMed ID: 8712728
    [Abstract] [Full Text] [Related]

  • 36. Cisplatin down-regulation of cellular Fas-associated death domain-like interleukin-1beta-converting enzyme-like inhibitory proteins to restore tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human melanoma cells.
    Song JH, Song DK, Herlyn M, Petruk KC, Hao C.
    Clin Cancer Res; 2003 Sep 15; 9(11):4255-66. PubMed ID: 14519653
    [Abstract] [Full Text] [Related]

  • 37. Growth inhibition of human lung cancer cell lines by interleukin 6 in vitro: a possible role in tumor growth via an autocrine mechanism.
    Takizawa H, Ohtoshi T, Ohta K, Yamashita N, Hirohata S, Hirai K, Hiramatsu K, Ito K.
    Cancer Res; 1993 Sep 15; 53(18):4175-81. PubMed ID: 8364912
    [Abstract] [Full Text] [Related]

  • 38. Overexpression of Interleukin-6 suppresses cisplatin-induced cytotoxicity in esophageal squamous cell carcinoma cells.
    Suchi K, Fujiwara H, Okamura S, Okamura H, Umehara S, Todo M, Furutani A, Yoneda M, Shiozaki A, Kubota T, Ichikawa D, Okamoto K, Otsuji E.
    Anticancer Res; 2011 Jan 15; 31(1):67-75. PubMed ID: 21273582
    [Abstract] [Full Text] [Related]

  • 39. Sensitivity of resistant human tumor cell lines to tumor necrosis factor and adriamycin used in combination: correlation between down-regulation of tumor necrosis factor-messenger RNA induction and overcoming resistance.
    Safrit JT, Bonavida B.
    Cancer Res; 1992 Dec 01; 52(23):6630-7. PubMed ID: 1330298
    [Abstract] [Full Text] [Related]

  • 40. Sensitization of immunoresistant prostate carcinoma cell lines to Fas/Fas ligand-mediated killing by cytotoxic lymphocytes: independence of de novo protein synthesis.
    Frost PJ, Belldegrun A, Bonavida B.
    Prostate; 1999 Sep 15; 41(1):20-30. PubMed ID: 10440872
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.